CLINICAL STUDIESA novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial >>
PUBLICATIONSMore than forty five Supportive Statements and Publications about NEUROASPIS since 1997 >>
23.02.2018 NEUROASPIS LAUNCH IN CZECH REPUBLIC
Aniva Int. reached an agreement for the launch of its brand NEUROASPIS (the first supplement with Clinical Study and World Patent for Multiple Sclerosis and related Neurodegenerative diseases) in Czech Republic through a specialized company in health care of patients with neurological disorders. This agreement comes after the launch of Neuroaspis in Slovakia and ongoing discussions in […]
28.11.2017 NEUROASPIS® plp10 at XI/XVII Congress of Serbian Neurologists with International Participation
NEUROASPIS® plp10 was presented at XI/XVII Congress of Serbian Neurologists with International Participation will was held in Belgrade from 24 to 26.11.2017 .